Related Experiment Video
Updated: Feb 4, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Limitations of ventricular assist devices in pediatrics: When one size does not fit all
Áine Lynch1,2, Aamir Jeewa1,2
1Division of Pediatric Cardiology, Columbia University Medical Center, New York Presbyterian Morgan Stanley Children's Hospital, New York, NY.
Insights
Pediatric heart failure patients need better ventricular assist devices (VADs). Body size impacts outcomes, and a lack of pediatric VADs limits care, especially for smaller children.
Area of Science:
- Pediatric Cardiology
- Biomedical Engineering
- Mechanical Circulatory Support
Background:
- Ventricular assist device (VAD) use is increasing in pediatric heart failure.
- Limited VAD options exist for infants and children, with many using adult devices.
- Body size is a critical factor influencing VAD outcomes in pediatric patients.
Purpose of the Study:
- To review the current landscape of VAD use in pediatric heart failure.
- To highlight the challenges posed by the lack of pediatric-specific VADs.
- To emphasize the impact of body size on VAD outcomes and survival.
Main Methods:
- Review of current literature on VADs in pediatric heart failure.
- Analysis of factors affecting VAD outcomes, including device type and patient characteristics.
- Examination of the disparity between adult and pediatric VAD device availability.
Main Results:
- Patients who can utilize adult-sized implantable continuous-flow VADs show improved survival and fewer complications.
- Smaller pediatric patients often require extracorporeal VAD support, which is associated with poorer outcomes.
- Body size is an independent predictor of mortality and adverse events in pediatric VAD recipients.
Conclusions:
- There is a significant need for the development of VADs specifically designed for pediatric patients.
- Optimizing VAD care for children requires addressing the limitations of current device options.
- Pediatric-specific VADs are essential to improve survival and reduce complications in this population.
Abstract:
Ventricular assist device (VAD) use in pediatric heart failure is an evolving field with increasing volume and case complexity of patients supported. Despite this, limited VADs used are developed for infants and children, with significant numbers supported using adult devices. While outcomes on support are influenced by a variety of factors, including illness severity at VAD implant, need for additional right heart support, and presence of congenital heart disease, body size remains an independent predictor of mortality and adverse events on VAD support. Those patients able to accommodate adult-designed implantable continuous-flow VADs experience markedly improved survival outcomes and lower complication rates with improved rehabilitation potential. For the remaining cohort, device choices are limited to extracorporeal VAD support with inferior outcomes and care limited to hospital settings. The deficit in pediatric-specific VAD devices is a well-recognized need to optimize care for this complex cohort.
Related Concept Videos
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Inclusive Fitness
Limiting Reactant
Goodness-of-Fit Test
The Number e as a Limit
Types of Limits I

